Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
4
×
covid-19
fda
biogen
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
deerfield management
detroit blog main
detroit top stories
diabetes
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
ipo
life sciences
medicine
melinta therapeutics
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
venture capital
wisconsin blog main
What
covid
4
×
new
bio
ipo
medical
medicines
roundup
acquisitions
activity
announced
approvals
assistant
ban
banned
battle
biogen
boost
cancer
center
ceo
clamped
collabs
content
coronavirus
dangerous
daniel
day
deal
delays
dermatology
developing
doesn’t
dr
economic
engadget
expanded
fast
fda
felt
gilead
Language
unset
Current search:
covid
×
cancer
×
@techcrunch.com
2 years ago
YouTube will now ban content with vaccine misinformation
@engadget.com
3 years ago
Telehealth got a huge boost from COVID-19. Now what?
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
